Randomised study of n of 1 trials versus standard practice
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Objective : To compare outcomes between groups of patients with irreversible chronic airflow limitation given theophylline by n of 1 trials or standard practice. Design : Randomised controlled study of n of 1 trials versus standard practice. Setting : Tertiary care centre outpatient department. Subjects : 31 patients with irreversible chronic airflow limitation who were unsure that theophylline was helpful after an open trial. Interventions : n Of 1 trials (single patient randomised multiple crossover comparisons of theophylline against placebo) followed published guidelines. For standard practice patients theophylline was stopped and resumed if their dyspnoea worsened; if their dyspnoea then improved theophylline was continued. For both groups a decision to continue or stop the drug was made within three months of randomisation. Main outcome measures : Exercise capacity as measured by six minute walking distance, quality of life as measured by the chronic respiratory disease questionnaire at baseline and six months after randomisation, and proportions of patients taking theophylline at six months. Results : 26 patients completed follow up. 47% fewer n of 1 trial patients than standard practice patients were taking theophylline at six months (5/14 versus 10/12; 95% confidence interval of difference 14% to 80%) without differences in exercise capacity or quality of life. Conclusions : n Of 1 trials led to less theophylline use without adverse effects on exercise capacity or quality of life in patients with irreversible chronic airflow limitation. These data directly support the presence of a clinically important bias towards unnecessary treatment during open prescription of theophylline for irreversible chronic airflow limitation. Confirmation in a larger study and similar studies for other problems appropriate for n of 1 trials are needed before widespread use of n of 1 trials can be advocated in routine clinical practice. Key messages: Several common clinical problems suit n of 1 tri- als, including prescription of theophylline for irre- versible chronic airflow limitation, yet they are rarely used Among patients with chronic airflow limitation randomised to receive theophylline by an n of 1 trial or standard practice 47% fewer n of 1 trial patients were taking theophylline after six months without difference in exercise capacity or quality of life There seems to be a clinically important bias towards unnecessary treatment in standard prac- tice in this setting; n of 1 trials may limit this bias
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
A measure of quality of life for clinical trials in chronic lung disease
Guyatt, G. H., Berman, L. B., Townsend, M., Pugsley, S. O., & Chambers, L. W. (1987) · Thorax · doi:10.1136/thx.42.10.773 · Cited by 1,721
Cited by
Guyatt, G. H., Haynes, R. B., Jaeschke, R. Z., Cook, D. J., Green, L., Naylor, C. D., Wilson, M. C., Richardson, W. S., & for the Evidence-Based Medicine Working Group (2000) · JAMA · doi:10.1001/jama.284.10.1290 · Cited by 748
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Lillie, E. O., Patay, B., Diamant, J., Issell, B., Topol, E. J., & Schork, N. J. (2011) · Personalized Medicine · doi:10.2217/pme.11.7 · Cited by 706
Are randomized clinical trials good for us (in the short term)? Evidence for a “trial effect”
Braunholtz, D. A., Edwards, S. J. L., & Lilford, R. J. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00305-x · Cited by 539
Evidence‐based practice in clinical psychology: What it is, why it matters; what you need to know
Spring, B. (2007) · Journal of Clinical Psychology · doi:10.1002/jclp.20373 · Cited by 388
N-of-1 Trials in the Medical Literature: A Systematic Review
Gabler, N. B., Duan, N., Vohra, S., & Kravitz, R. L. (2011) · Medical Care · doi:10.1097/mlr.0b013e318215d90d · Cited by 226
“Condition under study Neuropsychiatric (other than ADHD) F 29 (27) Pulmonary F 14 (13) Musculoskeletal (other than osteoarthritis) F 13 (12) Gastrointestinal F 12 (11) ADHD F 10 (9)”
BackgroundCustomization of Pain Treatments: Single-Case Design and Analysis
Onghena, P., & Edgington, E. S. (2005) · The Clinical Journal of Pain · doi:10.1097/00002508-200501000-00007 · Cited by 188
N-of-1 (Single-Patient) Trials for Statin-Related Myalgia
Joy, T. R., Monjed, A., Zou, G. Y., Hegele, R. A., McDonald, C. G., & Mahon, J. L. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1921 · Cited by 130
Self-citationSystematic review to determine whether participation in a trial influences outcome
Vist, G. E., Hagen, K. B., Devereaux, P. J., Bryant, D., Kristoffersen, D. T., & Oxman, A. D. (2005) · BMJ · doi:10.1136/bmj.330.7501.1175 · Cited by 104
Single-subject research in psychiatry: facts and fictions
Zuidersma, M., Riese, H., Snippe, E., Booij, S. H., Wichers, M., & Bos, E. H. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.539777 · Cited by 54
Metadata
- Authors
- Mahon, J., Laupacis, A., Donner, A., & Wood, T.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1996-04-27
- Volume
- 312
- Issue
- 7038
- Pages
- 1069-1074
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2094947411
- Cited by
- 104
- References
- 2
- FWCI
- 6.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.